← Eichor
Condition: Psychosis Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Psychosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder
NA · 1 location(s) · McMaster University · NCT07213492Vulnerability/Resilience Factors Influencing the Developmental Trajectories and Adaptive Methods of Children and Adolesc
Phase N/A · 5 location(s) · University Hospital, Rouen · NCT05525962A Bioequivalence Study of PP3M in Patients With Schizophrenia
NA · 1 location(s) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. · NCT07493551SPARK Healthy Sleep
NA · 1 location(s) · Indiana University · NCT07119268An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Phase 2 · 3 location(s) · MapLight Therapeutics · NCT07459660Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates
Phase 4 · 1 location(s) · Corporal Michael J. Crescenz VA Medical Center · NCT03495024Psychiatric Multi-omics and Neuroimaging Project
Phase N/A · 1 location(s) · mingjun Zhong · NCT06580860A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
NA · 1 location(s) · New York University · NCT06508450Efficacy and Safety of tACS vs tDCS in Schizophrenia
NA · 1 location(s) · All India Institute of Medical Sciences, Bhubaneswar · NCT06494124MicroRNAs as Biomarkers in First Episode Schizophrenia
NA · 1 location(s) · Northwell Health · NCT07703670Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
Phase 3 · 20 location(s) · Neurocrine Biosciences · NCT07227818Randomized Withdrawal Study in Patients With Schizophrenia
Phase 3 · 22 location(s) · Vanda Pharmaceuticals · NCT06961968The VIA Family 2.0 - a Family Based Intervention for Families with Parental Mental Illness
NA · 1 location(s) · Mental Health Centre Copenhagen, Bispebjerg and Frederiksber · NCT06312410Brain Circuitry Therapeutics for Schizophrenia
NA · 2 location(s) · Indrit Begue · NCT06341517Biomarkers to Enhance Early Schizophrenia Treatment
Phase 4 · 5 location(s) · Northwell Health · NCT06969755Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Phase 4 · 24 location(s) · VA Office of Research and Development · NCT04373317A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · 129 location(s) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Dise
Phase 3 · 22 location(s) · Bristol-Myers Squibb · NCT06947941Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
Phase 1 · 5 location(s) · BioXcel Therapeutics Inc · NCT05025605Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spect
Phase 3 · 61 location(s) · Intra-Cellular Therapies, Inc. · NCT06229210Evaluation of the Supported Housing System for the Inclusion of People Suffering From Mental Disorders
NA · 1 location(s) · Centre Hospitalier St Anne · NCT06636474Examining the Efficacy of a Virtual Reality Cognitive Remediation Program for People Living With Psychosis
NA · 1 location(s) · The Royal Ottawa Mental Health Centre · NCT05973110Digital Navigators for Acceptance and Competence Development with Mental Health Apps
NA · 6 location(s) · Medizinische Hochschule Brandenburg Theodor Fontane · NCT06575582Skills Group for Youth at Clinical High-Risk for Psychosis
NA · 1 location(s) · University of Pittsburgh · NCT05398120PS-Trauma - Development of Trauma Treatment for Patients With Co-morbid Psychotic Disorders and Traumas
NA · 1 location(s) · Nikolai Albert · NCT07242586"Extended" (Alternate Day) Antipsychotic Dosing
Phase 4 · 1 location(s) · Centre for Addiction and Mental Health · NCT04478838Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations
NA · 1 location(s) · University Hospital, Caen · NCT05550155Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness
Phase 2 · 2 location(s) · Brigham and Women's Hospital · NCT06376734Going to Altitude With Anxious-depressive Symptoms
NA · 1 location(s) · Universitaet Innsbruck · NCT05323864Study on the Role and Mechanism of Plasma Exosome microRNAs in Cognitive Impairment in First-episode Schizophrenia
Phase N/A · 1 location(s) · Tianjin Anding Hospital · NCT07139171
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.